日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ
  1. 詳細表示 / 
  2. アイテムの概要

アイテム詳細

登録内容を編集ファイル形式で保存
一時保存へ追加
  タグ情報を表示リリース履歴を表示詳細要約

公開
学術論文

Towards the sustainable discovery and development of new antibiotics

MPS-Authors
/persons/resource/persons256033

Bode,  Helge B.
Natural Product Function and Engineering, Department of Natural Products in Organismic Interactions, Max Planck Institute for Terrestrial Microbiology, Max Planck Society;

External Resource

https://doi.org/10.1038/s41570-021-00313-1
(出版社版)

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

Miethke, M., Pieroni, M., Weber, T., Bronstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., Moreira, R., Li, Y., Luzhetskyy, A., Medema, M. H., Pernodet, J.-L., Stadler, M., Tormo, J. R., Genilloud, O., Truman, A. W., Weissman, K. J., Takano, E., Sabatini, S., Stegmann, E., Brotz-Oesterhelt, H., Wohlleben, W., Seemann, M., Empting, M., Hirsch, A. K. H., Loretz, B., Lehr, C.-M., Titz, A., Herrmann, J., Jaeger, T., Alt, S., Hesterkamp, T., Winterhalter, M., Schiefer, A., Pfarr, K., Hoerauf, A., Graz, H., Graz, M., Lindvall, M., Ramurthy, S., Karlen, A., van Dongen, M., Petkovic, H., Keller, A., Peyrane, F., Donadio, S., Fraisse, L., Piddock, L. J. V., Gilbert, I. H., Moser, H. E., & Muller, R. (2021). Towards the sustainable discovery and development of new antibiotics. Nature Reviews Chemistry, 5(10), 726-749. doi:10.1038/s41570-021-00313-1.


引用: https://hdl.handle.net/21.11116/0000-000A-054C-C
要旨
An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the current level of investment in their development, particularly in the fields of natural-product-derived and synthetic small molecules. New agents displaying innovative chemistry and modes of action are desperately needed worldwide to tackle the public health menace posed by antimicrobial resistance. Here, our consortium presents a strategic blueprint to substantially improve our ability to discover and develop new antibiotics. We propose both short-term and long-term solutions to overcome the most urgent limitations in the various sectors of research and funding, aiming to bridge the gap between academic, industrial and political stakeholders, and to unite interdisciplinary expertise in order to efficiently fuel the translational pipeline for the benefit of future generations.